The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2015 | Global challenges for new cancer therapies
There is an increasing spectrum of available therapies for patients with cancer, which has improved the outcomes of varied cancer types. At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Robin Foà, MD, from Sapienza University, Rome, Italy, explains some of the challenges with improving sustainability, access and quality of new treatments around the world.
